0001755882-19-000003.txt : 20191009 0001755882-19-000003.hdr.sgml : 20191009 20191008181706 ACCESSION NUMBER: 0001755882-19-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191009 DATE AS OF CHANGE: 20191008 EFFECTIVENESS DATE: 20191009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aeovian Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001710088 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-350655 FILM NUMBER: 191143442 BUSINESS ADDRESS: STREET 1: 8001 REDWOOD BLVD. CITY: NOVATO STATE: CA ZIP: 94945 BUSINESS PHONE: (415) 209-2055 MAIL ADDRESS: STREET 1: 8001 REDWOOD BLVD. CITY: NOVATO STATE: CA ZIP: 94945 FORMER COMPANY: FORMER CONFORMED NAME: Delos Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20170622 D 1 primary_doc.xml X0708 D LIVE 0001710088 Aeovian Pharmaceuticals, Inc. 712 Bancroft Road #241 Walnut Creek CA CALIFORNIA 94598 (415) 209-2055 DELAWARE Delos Pharmaceuticals, Inc. Corporation true Stelios Tzannis 712 Bancroft Road #241 Walnut Creek CA CALIFORNIA 94598 Executive Officer Director Jens Eckstein 712 Bancroft Road #241 Walnut Creek CA CALIFORNIA 94598 Director Ben Zadik 712 Bancroft Road #241 Walnut Creek CA CALIFORNIA 94598 Executive Officer Michael Powell 712 Bancroft Road #241 Walnut Creek CA CALIFORNIA 94598 Director Richard Gaster 712 Bancroft Road #241 Walnut Creek CA CALIFORNIA 94598 Director Pharmaceuticals Decline to Disclose 06b false 2019-09-24 true true false 0 48799907 18799907 30000000 Total Amount Sold includes certain conversions of indebtedness and satisfaction of payment for prior services. false 5 0 0 0 false Aeovian Pharmaceuticals, Inc. /s/ Stelios Tzannis Stelios Tzannis Chief Executive Officer 2019-10-07